October 18, 2011
Minoru Urushibata, advisor to the Japan Pharmaceutical Association (JPA), discussed next year’s revision of medical fees and NHI drug pricing reform at a seminar held by Cegedim Strategic Data K.K.’s Uto Brain Division in Tokyo on October 17. “I think...read more